Skip to main content
Reproductive Medicine and Biology logoLink to Reproductive Medicine and Biology
. 2011 May 3;10(3):121–129. doi: 10.1007/s12522-011-0081-x

Advances in the study of the peripheral nervous system for erection in animals and humans

Shin‐ichi Hisasue 1,
PMCID: PMC5906884  PMID: 29699088

Abstract

Introduction

Since Walsh first emphasized the importance of preserving the neurovascular bundle n to protect the cavernous nerve during pelvic surgery, patients’ sexual life quality has dramatically improved. Today, nerve‐sparing radical prostatectomy is the established gold standard for organ‐confined prostate cancer patients. Recent technical advances in functional assessment such as intraoperative electrical stimulation have unveiled new anatomical features and physiological roles. Basic research has advanced understanding of cavernous nerve function, while molecular biology has uncovered the crucial role of neuronal nitric oxide in mediating erection, and has led to new treatments such as phosphodiesterase type‐5 inhibitors. A recent focus in cavernous nerve research concerns the nerve distribution external to the neurovascular bundle. The cavernous nerves in humans appear to be distributed more widely beneath the lateral pelvic fascia than in other animals, and electrical stimulation studies suggest possible involvement of these nerves in erection. These findings have prompted new surgical techniques such as the “veil of Aphrodite”, or “intrafascial nerve‐sparing” procedures.

Materials and Methods

These recent anatomical and physiological studies in humans and animals and their impact are reviewed in this article.

Conclusions

Further investigation should stimulate future advances in strategies to preserve erectile function in RP patients.

Keywords: Animal, Cavernous nerve, Erectile function, Human, Neuronal NO synthase, Radical prostatectomy, Rat

Animals

History of animal studies of erectile function

Animal research on penile erection dates from at least the latter half of the nineteenth century when Eckhard reported pelvic nerve involvement in erection in dogs [1]. Langley [2] introduced the term ‘autonomic nervous system’ and also coined the designation ‘parasympathetic’ in accord with his insights into the selective stimulatory action on fibers contained in the cranial and sacral outflows. In the twentieth century, pelvic neuroanatomic investigators had reached a consensus regarding the primary importance of the pelvic nerve plexus [3]. In 1968, technical advances enabled Lewis [4] to measure the intracavernous pressure (ICP) in bulls. Subsequently, several animal models were developed to investigate erectile function including studies in monkeys, dogs and rabbits. In the 1980s Sjöstrand [5] used plethysmography to quantify penile erection in rabbits, and Lue and co‐workers and Goldstein and co‐workers conducted experiments in monkeys, dogs and rabbits to show the hemodynamic events in the penis and the crucial role of cavernosal smooth muscle [6, 7, 8]. Epoch‐making experiments using commercially available small animals, rats and mice, were conducted in the last decade.

Walsh, the pioneer of nerve‐sparing radical prostatectomy (RP) in humans, and his co‐workers pioneered studies on penile erection using rats and their innovations enabled others to conduct erectile function studies more easily, resulting in significant progress in this research field [9]. More recently Burnett's and co‐workers reported the first experiments to use mice [10]. The addition of transgenic mice enabled experiments intended to expand our physiological and pharmacological understanding of erection [11, 12]. The neuroanatomy and physiology of the penis in rats and mice were gradually elucidated, and contemporary knowledge and technical advances will ensure further progress in this field [13].

Evaluation of erectile response in animals

Penile erection is a hemodynamic event, the consequence of relaxation of its smooth muscle, which involves both the central nervous system and local factors. The current basic concepts of erectile physiology result from in vivo and in vitro experiments, mostly performed in animals [14, 15]. In the flaccid state, the cavernous tissues are contracted by dominant sympathetic control of the arterioles and the cavernous smooth muscles [14]. Following sexual stimulation, increased parasympathetic nerve activity induces relaxation of cavernous tissue smooth muscle reducing resistance to blood flow resulting in a large influx of blood and a rapid increase in ICP. In this phase, reflex contraction of the ischiocavernous and bulbocavernous muscles also enhances the peak pressure, which rises to well above the arterial blood pressure and provides maximum rigidity to the penis. Simultaneously, the blood outflow from the cavernosum is decreased due to passive compression of the veins secondary to sinusoid expansion (venous occlusion) [16]. ICP recording is the gold standard for quantitating penile erection in animals [17]. The most common technique to induce erection is electrical field stimulation of specific sites in the nervous system responsible for erection.

Sites for electrical stimulation in animal experiments

Every site in the neural pathway responsible for erection can be used for electrical stimulation including the medial preoptic area (MPOA) in the hypothalamus, the pelvic ganglia, and the pelvic and cavernous nerves (CNs) [18]. Electrical stimulation of the MPOA was first proposed by Giuliano [19] and is thought to induce the most physiological erection because the MPOA is the central control of penile erection [18, 20].

Stimulation of the CNs to induce erection was first proposed by Quinlan [9]. The CN is the terminal part of the neural pathway of penile erection, and is located immediately proximal to the target organ, i.e., the corpus cavernosum. CNs in rats originate from the bilateral major pelvic ganglion (MPG) and mainly from the posterolateral surface of the prostate toward the corpus cavernosum (Fig. 1). In the RP nerve‐injury model, electrical stimulation of the CN itself following CN injury is technically difficult because it is necessary to stimulate proximal to the injury site. However, the pelvic ganglia and pelvic nerve located superior to the pelvic ganglia are alternative stimulation sites [21].

Figure 1.

Figure 1

Representative anatomical view around the MPG of rats. MPG major pelvic ganglia, PN pelvic nerve, CN cavernous nerve

ICP monitoring in rats

ICP measurement provides the most direct assessment of erectile function and makes objective evaluation of even subtle erectile responses possible, while it also facilitates a physiological approach and has expanded the understanding of penile erection. ICP is most commonly studied in rats [17]. One of the advantages of using the rat is the simple anatomy of the peripheral nervous system. The CN and the MPG, where the CN originates, are easily identified and the MPG represents the center of the pelvic nervous system (Fig. 1). The unilateral MPG in rats consists of ‘one ganglion’; it is neither a ‘plexus’ nor a ‘complex of several ganglia’, common features in other mammals [22]. Moreover, behavioral studies and other neurophysiological studies can be combined in the same study group [23]. Models of pathophysiological erectile dysfunction (ED) are easily created in rats including models of diabetes, aging, castration, CN injury, etc. [24, 25, 26, 27].

Similarities in the anatomy and neurophysiology of penile erection between rats and humans are limited compared with the reproductive organ responsible for ejaculation. Recently, the CN distribution in humans was reported to be broadly distributed around the prostate rather than confined to the neurovascular bundle [28]. In rats the ancillary nerve is as important as the main CN [29]. Sato et al. investigated the effects of unilateral and bilateral transection of the CN (main penile nerve) on the increase in ICP following MPOA stimulation in male rats (Fig. 2). Unilateral main penile nerve transection induced a 28% decrease of ICP while bilateral transection led to a 55% decrease of ICP. In other words, even after bilateral transection of the CN, significant increases in the ICP response following central stimulation were observed. The result suggested that the ancillary penile nerves, which originate from the major pelvic ganglia, have a complementary role to the CNs in the autonomic innervation of the penis.

Figure 2.

Figure 2

Schematic diagram of the relative contributions of the various neural pathways to the MPOA‐stimulated ICP response. Shown in parentheses are the approximate percent contribution of each penile nerve branch to the MPOA‐stimulated increase in ICP, where the ICP response elicited by the MPOA stimulation in the nerve intact condition is depicted as 100%. (adopted from the literature with permission [29])

CN injury model in animal studies

Clinically, nerve‐sparing techniques in RP dramatically improve recovery of erectile function; however, recovery is still insufficient to achieve full function [30], hence preclinical research in this field remains essential [27]. Various types of CN injury have been tested in rodents, especially in rats. These models were stratified (from less severe to more severe) by the extent of the injury, which included crushing, freezing, transecting, and excising. Table 1 shows the CN injury models in which functional assessment by ICP was performed. The least severe model is considered to be the crush model. Interestingly, however, exposure alone of the CN affected erectile function as well as the crush models [31, 32]. Neither the crush model for the nerve‐sparing RP nor the freezing model for cryoablation disrupted the nerve continuity and both preserved the nerve sheath. As an example of more severe CN injury, transection/excision techniques were used as non‐nerve sparing or nerve destruction models with a subsequent nerve graft technique.

Table 1.

Cavernous nerve injury models analyzed by ICP

Author Type of injury Side Time frame
Mullerad et al. [31] Exposure, crush, transection Bilateral 3, 10, 28 days
Yamashita et al. [32] Exposure Bilateral 1, 2, 4, 8 weeks
Sezen et al. [78] Crush Unilateral, bilateral 1, 3, 7 days
Lagoda et al. [79] Crush Unilateral, bilateral 14 days
Mulhall et al. [80] Crush Bilateral 28 days
Muller et al. [81] Crush Bilateral 10 days
Cangven et al. [82] Crush Bilateral 7 days
El‐sakka et al. [43] Freezing Unilateral 1, 3 months
Paick and Lee [83] Transection Bilateral 0 days
Giuliano et al. [18] Transection Unilateral CN and lumber sympathetic chain 0 days
Sato et al. [29] Transection Unilateral, bilateral, main CN and ancillary penile nerve 0 days
Quinlan et al. [9] Transection, excision Bilateral 0, 7, 30 days
Ball et al. [84] Excision Bilateral 2, 4 months
Jung et al. [85] Excision Unilateral 1, 3 months
Burnett and Becker [86] Transection, excision Bilateral 28 days
Allaf et al. [87] Transection, excision Unilateral 14 days
Syme et al. [88] Excision Bilateral 3 months
Connolly et al. [89] Excision Bilateral 1, 3 months
Hisasue et al. [20] Transection, excision Bilateral 1, 3 months

CN cavernous nerve

The timing of the assessment following CN injury is important to standardize CN injury experiments. The time frames differed among the experiments (Table 1). Some of the transection/excision rats were used to investigate the immediate effect of CN injury, but most were used for the CN reconstruction with a graft or a conduit. These experiments needed a relatively longer period (around 3 months) [20, 33].

For less damaging techniques which were used as a nerve‐sparing model, a relatively shorter time frame is required. In the crush model, even animals without proerectile treatment could recover from ED over a long‐term period, generally over 2 months, thus postoperative assessment within 1 month is generally accepted (data not shown). In adulthood, each rat month is roughly equivalent to 2.5 human years [34]. Most publications indicate that erectile function recovery plateaus at 12–24 months in humans following nerve‐sparing RP [35, 36, 37], although some recent reports describe further recovery beyond 24 months [38, 39]. Therefore, 1 month (2.5 years in humans) is a reasonable time frame to assess the nerve‐sparing technique in rats [40].

Regeneration or collateral sprouting of CN and neuronal nitric oxide synthase (nNOS) in rats

Transection of myelinated fibers (sensory or motor‐nerve) results in distal fragmentation of the axon and myelin sheaths [41]. Regenerating axonal sprouts grow in association with Schwann cells attracted by a gradient of neurotrophic factors. Axonal reconnections with the periphery, formation of synaptic buttons, maturation of the nerve fiber and its reprojection to the target organ are induced. Immunohistochemistry is generally used for histological confirmation of regenerated CN fibers. Nitric oxide (NO) produced by nNOS has been identified as one of the neurotransmitters involved in the non‐adrenergic non‐cholinergic pathway related to penile erection [42]. CN injury causes a decrease in nNOS‐positive nerve fibers in the penis, and apoptosis of cavernous smooth muscle subsequently occurs [43, 44]. The penis contains sympathetic, parasympathetic, and sensory nerves; however, the presence of nerve fibers themselves does not guarantee regeneration of the erectile neural pathway, only the identification and quantification of nNOS‐containing nerve fibers confirms CN regeneration.

The functional recovery of CN: aging and neurotrophic factor

Clinically, aging prolongs functional recovery from ED following RP [30]. Seventy‐six percent of patients <60 years old experienced functional recovery, compared with only 47% of those over 65 years [45]. The mechanism, which reduces neural plasticity with aging, remains unknown. Our previous experiments in models of unilateral CN injury suggested that post‐ganglionic projecting neurons originating in the intact side would be most likely to contribute to erectile functional recovery via a plastic change such as nerve sprouting [33]. Possibly nerve regeneration is slower in aged animals and more likely to undergo secondary deterioration [46]. Axonal regeneration and collateral sprouting may be promoted by neurotrophic factors derived from the target organ [47], but possibly aging might compromise expression of neurotrophic factors and receptors [48].

Neurotrophic factors produced by the target organs are delivered to the neuronal cell bodies by retrograde axonal transport [49, 50]. Neurturin and glial cell line‐derived neurotrophic factor (GDNF) have been proposed as neurotrophic factors of penis‐projecting neurons based on the finding [51] that 98.4% of penis‐projecting neurons in the pelvic ganglia were positive for GDNF family receptor alpha‐2 (GFRa2), a neurturin receptor. Moreover, GFRa2 is closely related to the development of nNOS‐positive neurons, and nNOS‐positive nerve fibers are diminished in GFRa2 knockout mice. Therefore, it is speculated that neurturin retrogradely supports nNOS‐positive neurons via GFRa2 [52]. Change with age in these conditions might adversely alter the neural plasticity needed for recovery from ED in RP patients.

Aging may be associated with decreases in nNOS‐positive neurons in the MPG and nerve fibers in the penis thereby impairing erectile function [53, 54]. The age‐dependent decrease of nNOS‐positive neurons found in our previous study was connected to a change in GFRa2 expression, which was induced by the interaction between nNOS and the neurturin−GFRa2 pathway. This outcome may be one of several factors underlying age‐related ED.

Humans

Discovery of an excellent landmark regarding the CN in humans

Walsh and Donker [55] first described the human anatomy basis for erection in 1982. ED following RP reflects injury to the pelvic nerve plexus which is the source of autonomic innervation to the corpus cavernosum. Recognition of the neurovascular bundle (NVB) including the CN is one of the great accomplishments of urological surgery and led to nerve‐sparing RP [30, 56], which today is an essential component of RP and dramatically improves postoperative erectile function [57]. Despite this major advance, post‐RP ED rates still vary widely from 15 to 91% [58]. Usually erectile function after RP gradually recovers after a period of complete absence of spontaneous erection. Consequently surgeons still face the challenge of improving the recovery rate and shortening the duration of ED; goals which may require new approaches to rehabilitation [59] and novel nerve‐sparing techniques [60].

New observations on the course of the CN

Initially it was believed that the CN ran adjacent to the NVB in the posterolateral aspect of the prostate from the base of the prostate to its apex. Subsequently it was determined that the CN joined the NVB at a point distal or inferior to the bladder−prostate junction (Fig. 3) [48, 61]. A recent 3D computer‐assisted anatomical dissection study confirmed that CN fibers do not strictly follow the NVB course, but are distributed at several levels, in a fan‐like formation [62]. Other recent reports also suggest that the periprostatic CN is more diffuse than initially believed [48, 49, 61]. In patients with no definite NVB formation observed on magnetic resonance imaging, the nerves associated with erectile function may run along both sides of the prostate and spread more anteriorly than occurs when the NVB is more clearly observed [63]. During early fetal development the fibers of the CN enclose the prostatic and membranous urethra dorsally and laterally. As the prostate grows, the CNs running beside the prostate become displaced further anteriorly and spread, thus forming a concave shape (like a ‘curtain’) of the NVB [64]. Branches are distributed around the prostate on the prostatic fascia outside of the NVB, and possibly contribute to normal erectile function. Based on this possibility, new nerve‐sparing techniques such as the ‘veil of Aphrodite’ to preserve this function were proposed [60]. We performed immunohistochemical staining with nNOS‐antibody and divided the prostatic hemisphere into 6 zones to assess the distribution of nNOS‐positive nerve fibers at the apex, mid‐portion, and base of the prostate. Sixty‐five percent of nNOS‐positive nerve fibers were distributed in a 3–5 O'clock sextant (P < 0.001).

Figure 3.

Figure 3

The scheme for the cavernous nerve course from the previous literature. In humans, cavernous nerves originate from the pelvic ganglia, and run posteriorly far from the NVB especially at the base of prostate level. Dotted lines represent the recommended incision line for ‘veil of Aphrodite’ (upper) and ‘the line for appropriate preservation of cavernous nerve’ (lower)

The definitive function of nerves outside of the NVB

Recently interest has focused on the CN exterior to the NVB with the belief that improved knowledge might lead to better preservation of pro‐erectile nerves. Conventional nerve‐sparing RP makes it possible to preserve around 55% of all periprostatic nerve fibers [65]; however, the definitive function of nerves exterior to the NVB remains controversial. Immunohistochemical studies with S‐100, a general neural marker, revealed that 30–40% of nerve fibers were exterior to the NVB [66].

Increased intracavernous or intraurethral pressures elicited by electrical stimulation of the anterior [28] and posterior surfaces [67] of the prostate indicate the existence of pro‐erectile nerve fibers outside of the NVB; however, these studies were performed in a limited number of patients and intraurethral pressure might not reflect true erectile function. In a detailed immunohistochemical study, Costello et al. [68] recently reported conflicting results in that only 11.1% of the nNOS‐positive nerve fibers were located on the anterior half of the prostate, and that most of the anterior nerves were sympathetic or somatic (Fig. 4). Furthermore, they also suggested that nNOS‐positive nerves on the anterior surface were most probably innervating the prostatic stroma. Indeed, NO synthase and phosphodiesterase type‐5 are reported to express in the prostate [69, 70]. Possibly, the anterior nerves contribute to smooth muscle relaxation in the prostate, but not in the penis. We found anterior fibers, but unlike the NVB region, they did not show the assumed compensatory increase in numbers in preoperative ED patients [71]. Further investigations will be necessary to clarify the definitive role of the nNOS‐positive nerves on the anterior aspect of the prostate.

Figure 4.

Figure 4

The scheme for the nerve distribution around the prostate. Left diagram shows the fiber distribution stratified by the nerve function based on the immunohistochemistry results. Right diagram shows the nNOS‐positive nerve fiber distribution around the prostate. The diagrams were made from the data adopted from the results by Costello et al. [68]

Existing clinical features and CN distribution

There is considerable individual variation in CN distribution although the reasons for this variation remain unclear [66]. There is no evidence to suggest that any preoperative clinical features influence the CN quantity. Rabbani et al. [45] suggested that better baseline erectile function and younger age convey a better prospect for erectile recovery. Others have suggested that prostate size does not influence the periprostatic fiber quantity [72].

Recently, we investigated 46 hemispheres of 23 non‐nerve‐sparing RP patient specimens [71]. We used a multivariate analysis to identify possible predictive factors for the quantity of overall nNOS‐positive nerve fibers. We included patient's age, prostate size (specimen weight), body mass index, international index of erectile function, and objective erectile function. We found no influence of these parameters on fiber quantity without the objective erectile function. The fiber count was greater in the objective ED group (1500: 382–2760) than in the non‐ED group (649: 156–2916) (P = 0.009). Thus, baseline erectile function greatly impacts CN quantity and distribution.

A possible explanation for the increased CN fibers in ED patients is collateral sprouting of nNOS‐positive nerve fibers, which might occur in the nNOS‐positive ganglionic neuronal soma located in the pelvic nerve plexus and/or on the prostate. In support of this hypothesis, nNOS‐positive nerve fibers in ED patients were significantly thinner than non‐ED patients [71]. Furthermore, the ganglionic neurons were recently suggested to distribute around the prostate [18, 66]. We found that CN quantity was similar at the base, but compared with non‐ED patients greater at the mid and apex zones in the ED patients; whereas quantity and distribution of nNOS‐positive ganglionic neurons did not differ. Chronic renal failure rats had significantly higher levels of nNOS mRNA and protein in the MPG and penile tissues than controls which might represent a compensatory increase of nNOS fibers to recover penile erectile function [73]. The impaired baseline erectile function which is related to damaged cavernous tissue or nerve terminals induced the collateral sprouting of nerve fibers around the prostate; this reaction being more marked in the distal portion [74].

The prostatic apex is the key anatomical region for NVB preservation. In our study, the fibers increased at the apex and are possibly thinner in ED patients [75]. Therefore, gentle and meticulous preservation, such as an early release of the NVB, is essential [76, 77]. This approach has been previously reported to provide better functional recovery, raising the possibility of traction injury and/or poor visualization [76]. Moreover, our study showed that more nNOS‐positive nerve fibers spread over the NVB to the 5–6 O'clock region in ED patients than in non‐ED patients [75]. Previously, in an intraoperative electrical stimulation study, Takenaka et al. [67] reported that posterior periprostatic CNs are responsible for erection, thus supporting the view that CN preservation in this area might contribute to preserving erectile function especially for patients with preoperative ED.

Conclusions

The CN is the essential autonomic peripheral nerve for normal erection, and its anatomical distribution is complex in both animals and humans. Its pathway in humans is not confined to the NVB and the CN runs posteriorly far from the NVB especially at the base of the prostate level, and forms a fan‐shaped distribution. Regarding the nerve fibers on the anterior surface, the nNOS‐positive fibers were few and had little influence on the erectile function. Furthermore, ED from chronic disease status may induce the compensatory increase of CN around the NVB. Studies on the peripheral nervous system with regard to erection in both animals and humans significantly advanced knowledge of the anatomical and physiological roles of the CN. Further investigation should stimulate future advances in strategies to preserve erectile function in RP patients.

References

  • 1. Burnett AL, Wesselmann U. History of the neurobiology of the pelvis. Urology, 1999, 53 (6) 1082–1089 10.1016/S0090‐4295(99)00070‐9 [DOI] [PubMed] [Google Scholar]
  • 2. Langley JN. On the reaction of cells and of nerve‐endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol, 1906, 33, 374–413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Davis AA. The innervation of the uterus. J Obstet Gynecol., 1933, 40, 481–497 [Google Scholar]
  • 4. Lewis JE, Walker DF, Beckett SD, Vachon RI. Blood pressure within the corpus cavernosum penis of the bull. J Reprod Fertil, 1968, 17, 155–156 10.1530/jrf.0.0170155 [DOI] [PubMed] [Google Scholar]
  • 5. Sjostrand NO, Klinge E, Himberg JJ. Effects of VIP and other putative neurotransmitters on smooth muscle effectors of penile erection. Acta Physiol Scand, 1981, 113 (3) 403–405 10.1111/j.1748‐1716.1981.tb06914.x [DOI] [PubMed] [Google Scholar]
  • 6. Lue TF, Zeineh SJ, Schmidt RA, Tanagho EA. Neuroanatomy of penile erection: its relevance to iatrogenic impotence. J Urol, 1984, 131 (2) 273–280 [DOI] [PubMed] [Google Scholar]
  • 7. Lue TF, Takamura T, Schmidt RA, Palubinskas AJ, Tanagho EA. Hemodynamics of erection in the monkey. J Urol, 1983, 130 (6) 1237–1241 [DOI] [PubMed] [Google Scholar]
  • 8. Azadzoi KM, Payton T, Krane RJ, Goldstein I. Effects of intracavernosal trazodone hydrochloride: animal and human studies. J Urol, 1990, 144 (5) 1277–1282 [DOI] [PubMed] [Google Scholar]
  • 9. Quinlan DM, Nelson RJ, Partin AW, Mostwin JL, Walsh PC. The rat as a model for the study of penile erection. J Urol, 1989, 141 (3) 656–661 [DOI] [PubMed] [Google Scholar]
  • 10. Sezen SF, Burnett AL. Intracavernosal pressure monitoring in mice: responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration. J Androl, 2000, 21 (2) 311–315 [PubMed] [Google Scholar]
  • 11. Cashen DE, MacIntyre DE, Martin WJ. Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase. Br J Pharmacol, 2002, 136 (5) 693–700 10.1038/sj.bjp.0704772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Behr‐Roussel D, Darblade B, Oudot A, Compagnie S, Bernabe J, Alexandre L et al. Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice. J Sex Med., 2006, 3 (4) 596–603 10.1111/j.1743‐6109.2006.00282.x [DOI] [PubMed] [Google Scholar]
  • 13. Andersson KE. Penile erectile function: recommendations for future research. Int J Impot Res, 2000, 12 (Suppl 4) S163–S167 10.1038/sj.ijir.3900598 [DOI] [PubMed] [Google Scholar]
  • 14. Saenz de Tejada I, Angulo J, Cellek S, Gonzalez‐Cadavid N, Heaton J, Pickard R et al. Physiology of erectile function. J Sex Med, 2004, 1 (3) 254–265 10.1111/j.1743‐6109.04038.x [DOI] [PubMed] [Google Scholar]
  • 15. Andersson KE. Pharmacology of erectile function and dysfunction. Urol Clin North Am, 2001, 28 (2) 233–247 10.1016/S0094‐0143(05)70134‐8 [DOI] [PubMed] [Google Scholar]
  • 16. Creed KE, Carati CJ, Keogh EJ. The physiology of penile erection. Oxf Rev Reprod Biol., 1991, 13, 73–95 [PubMed] [Google Scholar]
  • 17. Mehta N, Sikka S, Rajasekaran M. Rat as an animal model for male erectile function evaluation in sexual medicine research. J Sex Med, 2008, 5 (6) 1278–1283 10.1111/j.1743‐6109.2008.00854.x [DOI] [PubMed] [Google Scholar]
  • 18. Giuliano F, Bernabe J, Brown K, Droupy S, Benoit G, Rampin O. Erectile response to hypothalamic stimulation in rats: role of peripheral nerves. Am J Physiol, 1997, 273 (6 Pt 2) R1990–R1997 [DOI] [PubMed] [Google Scholar]
  • 19. Giuliano F, Rampin O, Brown K, Courtois F, Benoit G, Jardin A. Stimulation of the medial preoptic area of the hypothalamus in the rat elicits increases in intracavernous pressure. Neurosci Lett, 1996, 209 (1) 1–4 10.1016/0304‐3940(96)12594‐5 [DOI] [PubMed] [Google Scholar]
  • 20. Hisasue S, Kato R, Sato Y, Suetomi T, Tabata Y, Tsukamoto T. Cavernous nerve reconstruction with a biodegradable conduit graft and collagen sponge in the rat. J Urol, 2005, 173 (1) 286–291 10.1097/01.ju.0000141578.84536.80 [DOI] [PubMed] [Google Scholar]
  • 21. Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF et al. Herpes simplex virus vector‐mediated delivery of glial cell line‐derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Ther, 2007, 14 (18) 1344–1352 [DOI] [PubMed] [Google Scholar]
  • 22. Keast JR. Unusual autonomic ganglia: connections, chemistry, and plasticity of pelvic ganglia. Int Rev Cytol, 1999, 193, 1–69 10.1016/S0074‐7696(08)61778‐7 [DOI] [PubMed] [Google Scholar]
  • 23. Adaikan PG, Srilatha B. Oestrogen‐mediated hormonal imbalance precipitates erectile dysfunction. Int J Impot Res, 2003, 15 (1) 38–43 10.1038/sj.ijir.3900945 [DOI] [PubMed] [Google Scholar]
  • 24. Suetomi T, Hisasue S, Sato Y, Tabata Y, Akaza H, Tsukamoto T. Effect of basic fibroblast growth factor incorporating gelatin microspheres on erectile function in the diabetic rat. J Urol, 2005, 173 (4) 1423–1428 10.1097/01.ju.0000149034.49289.2b [DOI] [PubMed] [Google Scholar]
  • 25. Yamanaka M, Shirai M, Shiina H, Shirai M, Tanaka Y, Fujime M et al. Loss of anti‐apoptotic genes in aging rat crura. J Urol, 2002, 168 (5) 2296–2300 10.1016/S0022‐5347(05)64374‐1 [DOI] [PubMed] [Google Scholar]
  • 26. Suzuki N, Sato Y, Hisasue S, Kato R, Suzuki K, Tsukamoto T. Effect of testosterone on intracavernous pressure elicited with electrical stimulation of the medial preoptic area and cavernous nerve in male rats. J Androl, 2007, 28 (2) 218–222 10.2164/jandrol.106.000695 [DOI] [PubMed] [Google Scholar]
  • 27. Canguven O, Burnett A. Cavernous nerve injury using rodent animal models. J Sex Med, 2008, 5 (8) 1776–1785 10.1111/j.1743‐6109.2008.00955.x [DOI] [PubMed] [Google Scholar]
  • 28. Kaiho Y, Nakagawa H, Saito H, Ito A, Ishidoya S, Saito S et al. Nerves at the ventral prostatic capsule contribute to erectile function: initial electrophysiological assessment in humans. Eur Urol, 2009, 55 (1) 148–154 10.1016/j.eururo.2008.09.022 [DOI] [PubMed] [Google Scholar]
  • 29. Sato Y, Rehman J, Santizo C, Melman A, Christ GJ. Significant physiological roles of ancillary penile nerves on increase in intracavernous pressure in rats: experiments using electrical stimulation of the medial preoptic area. Int J Impot Res, 2001, 13 (2) 82–88 10.1038/sj.ijir.3900650 [DOI] [PubMed] [Google Scholar]
  • 30.Walsh PC, Mostwin JL (1984) Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve‐sparing technique. Br J Urol 56(6):694–7. [DOI] [PubMed]
  • 31. Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP. Functional sequelae of cavernous nerve injury in the rat: is there model dependency. J Sex Med, 2006, 3 (1) 77–83 10.1111/j.1743‐6109.2005.00158.x [DOI] [PubMed] [Google Scholar]
  • 32. Kruger K, Tam AS, Lu C, Sretavan DW. Retinal ganglion cell axon progression from the optic chiasm to initiate optic tract development requires cell autonomous function of GAP‐43. J Neurosci, 1998, 18 (15) 5692–5705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Kato R, Kiryu‐Seo S, Sato Y, Hisasue S, Tsukamoto T, Kiyama H. Cavernous nerve injury elicits GAP‐43 mRNA expression but not regeneration of injured pelvic ganglion neurons. Brain Res, 2003, 986 (1–2) 166–173 10.1016/S0006‐8993(03)03249‐9 [DOI] [PubMed] [Google Scholar]
  • 34.Ruth EB. Metamorphosis of the pubic symphysis. I. The white rat (Mus norvegicus albinus). Anat Rec. 1935;1–7.
  • 35. May F, Weidner N, Matiasek K, Caspers C, Mrva T, Vroemen M et al. Schwann cell seeded guidance tubes restore erectile function after ablation of cavernous nerves in rats. J Urol, 2004, 172 (1) 374–377 10.1097/01.ju.0000132357.05513.5f [DOI] [PubMed] [Google Scholar]
  • 36. Monacelli G, Spagnoli AM, Cigna E, Cascioli I. Use of vein grafts in emergency in peripheral nerve defect. Minerva Chir, 2002, 57 (3) 377–381 [PubMed] [Google Scholar]
  • 37. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol, 1991, 145 (5) 998–1002 [DOI] [PubMed] [Google Scholar]
  • 38. Murphy GF, Orgill DP, Yannas IV. Partial dermal regeneration is induced by biodegradable collagen‐glycosaminoglycan grafts. Lab Invest, 1990, 62 (3) 305–313 [PubMed] [Google Scholar]
  • 39. Kuchel GA, Zigmond RE. Functional recovery and collateral neuronal sprouting examined in young and aged rats following a partial neural lesion. Brain Res, 1991, 540 (1–2) 195–203 10.1016/0006‐8993(91)90507‐R [DOI] [PubMed] [Google Scholar]
  • 40. Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve‐sparing radical prostatectomy affects the recovery of erectile function. BJU Int, 2010, 105 (1) 37–41 10.1111/j.1464‐410X.2009.08775.x [DOI] [PubMed] [Google Scholar]
  • 41. Verdu E, Ceballos D, Vilches JJ, Navarro X. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst, 2000, 5 (4) 191–208 10.1046/j.1529‐8027.2000.00026.x [DOI] [PubMed] [Google Scholar]
  • 42. Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide‐like factor mediates nonadrenergic–noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest, 1991, 88 (1) 112–118 10.1172/JCI115266 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. El‐Sakka AI, Hassan MU, Selph C, Perinchery G, Dahiya R, Lue TF. Effect of cavernous nerve freezing on protein and gene expression of nitric oxide synthase in the rat penis and pelvic ganglia. J Urol, 1998, 160 (6 Pt 1) 2245–2252 [DOI] [PubMed] [Google Scholar]
  • 44. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post‐radical prostatectomy model of erectile dysfunction. J Urol, 2003, 169 (3) 1175–1179 10.1097/01.ju.0000048974.47461.50 [DOI] [PubMed] [Google Scholar]
  • 45. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol, 2000, 164 (6) 1929–1934 10.1016/S0022‐5347(05)66921‐2 [PubMed] [Google Scholar]
  • 46. Vaughan DW. Effects of advancing age on peripheral nerve regeneration. J Comp Neurol, 1992, 323 (2) 219–237 10.1002/cne.903230207 [DOI] [PubMed] [Google Scholar]
  • 47. Levi‐Montalcini R. The nerve growth factor: thirty‐five years later. EMBO J, 1987, 6 (5) 1145–1154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Bergman E, Fundin BT, Ulfhake B. Effects of aging and axotomy on the expression of neurotrophin receptors in primary sensory neurons. J Comp Neurol, 1999, 410 (3) 368–386 10.1002/(SICI)1096‐9861(19990802)410:3<368::AID‐CNE2>3.0.CO;2‐I [DOI] [PubMed] [Google Scholar]
  • 49. Bandtlow CE, Heumann R, Schwab ME, Thoenen H. Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO J, 1987, 6 (4) 891–899 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. DiStefano PS, Friedman B, Radziejewski C, Alexander C, Boland P, Schick CM et al. The neurotrophins BDNF, NT‐3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron, 1992, 8 (5) 983–993 10.1016/0896‐6273(92)90213‐W [DOI] [PubMed] [Google Scholar]
  • 51. Laurikainen A, Hiltunen JO, Thomas‐Crusells J, Vanhatalo S, Arumae U, Airaksinen MS et al. Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat. J Neurobiol, 2000, 43 (2) 198–205 10.1002/(SICI)1097‐4695(200005)43:2<198::AID‐NEU9>3.0.CO;2‐D [DOI] [PubMed] [Google Scholar]
  • 52. Hisasue S, Kato R, Suetomi T, Kato K, Suzuki K, Kobayashi K et al. Age‐related alteration of neurturin receptor GFRa2 and nNOS in pelvic ganglia. Neurobiol Aging, 2006, 27 (10) 1524–1530 10.1016/j.neurobiolaging.2005.07.016 [DOI] [PubMed] [Google Scholar]
  • 53. Carrier S, Nagaraju P, Morgan DM, Baba K, Nunes L, Lue TF. Age decreases nitric oxide synthase‐containing nerve fibers in the rat penis. J Urol, 1997, 157 (3) 1088–1092 10.1016/S0022‐5347(01)65147‐4 [PubMed] [Google Scholar]
  • 54. Dahiya R, Lin A, Bakircioglu ME, Huang ST, Lue TF. mRNA and protein expression of nitric oxide synthase and adrenoceptor alpha 1 in young and old rat penile tissues. Br J Urol, 1997, 80 (2) 300–306 [DOI] [PubMed] [Google Scholar]
  • 55. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol, 1982, 128 (3) 492–497 [DOI] [PubMed] [Google Scholar]
  • 56. Lepor H, Gregerman M, Crosby R, Mostofi FK, Walsh PC. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis. J Urol, 1985, 133 (2) 207–212 [DOI] [PubMed] [Google Scholar]
  • 57. Walsh PC. The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol, 2007, 177 (5) 1632–1635 10.1016/j.juro.2007.01.012 [DOI] [PubMed] [Google Scholar]
  • 58. Mulhall JP. Exploring the potential role of neuromodulatory drugs in radical prostatectomy patients. J Androl, 2009, 30 (4) 377–383 10.2164/jandrol.108.006866 [DOI] [PubMed] [Google Scholar]
  • 59. Mulhall JP. Penile rehabilitation following radical prostatectomy. Curr Opin Urol, 2008, 18 (6) 613–620 10.1097/MOU.0b013e3283136462 [DOI] [PubMed] [Google Scholar]
  • 60. Navarro X, Sutherland DE, Kennedy WR. Long‐term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol, 1997, 42 (5) 727–736 10.1002/ana.410420509 [DOI] [PubMed] [Google Scholar]
  • 61. Burgers JK, Nelson RJ, Quinlan DM, Walsh PC. Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol, 1991, 146 (2) 463–468 [DOI] [PubMed] [Google Scholar]
  • 62. Kriegsfeld LJ, Dawson TM, Dawson VL, Nelson RJ, Snyder SH. Aggressive behavior in male mice lacking the gene for neuronal nitric oxide synthase requires testosterone. Brain Res, 1997, 769 (1) 66–70 10.1016/S0006‐8993(97)00688‐4 [DOI] [PubMed] [Google Scholar]
  • 63. Brown TJ, Khan T, Jones KJ. Androgen induced acceleration of functional recovery after rat sciatic nerve injury. Restor Neurol Neurosci, 1999, 15 (4) 289–295 [PubMed] [Google Scholar]
  • 64. Nachemson AK, Lundborg G, Myrhage R, Rank F. Nerve regeneration and pharmacological suppression of the scar reaction at the suture site. An experimental study on the effect of estrogen‐progesterone, methylprednisolone‐acetate and cis‐hydroxyproline in rat sciatic nerve. Scand J Plast. Reconstr Surg, 1985, 19 (3) 255–260 [DOI] [PubMed] [Google Scholar]
  • 65. Sievert KD, Hennenlotter J, Laible IA, Amend B, Nagele U, Stenzl A. The commonly performed nerve sparing total prostatectomy does not acknowledge the actual nerve courses. J Urol, 2009, 181 (3) 1076–1081 10.1016/j.juro.2008.10.154 [DOI] [PubMed] [Google Scholar]
  • 66. Lee SB, Hong SK, Choe G, Lee SE. Periprostatic distribution of nerves in specimens from non‐nerve‐sparing radical retropubic prostatectomy. Urology, 2008, 72 (4) 878–881 10.1016/j.urology.2008.05.038 [DOI] [PubMed] [Google Scholar]
  • 67. Takenaka A, Tewari A, Hara R, Leung RA, Kurokawa K, Murakami G et al. Pelvic autonomic nerve mapping around the prostate by intraoperative electrical stimulation with simultaneous measurement of intracavernous and intraurethral pressure. J Urol, 2007, 177 (1) 225–229 10.1016/j.juro.2006.08.104 [DOI] [PubMed] [Google Scholar]
  • 68. Costello A, Dowdle B, Namdarian B, Murphy D. Immunohistochemical study of the cavernous nerves in the peri‐prostatic region (AUA abstract #1606). J Urol, 2009, 181 (4) 577 10.1016/S0022‐5347(09)61628‐1 [Google Scholar]
  • 69. Burnett AL, Maguire MP, Chamness SL, Ricker DD, Takeda M, Lepor H et al. Characterization and localization of nitric oxide synthase in the human prostate. Urology, 1995, 45 (3) 435–439 10.1016/S0090‐4295(99)80012‐0 [DOI] [PubMed] [Google Scholar]
  • 70. Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, Vita G et al. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med., 2010, 7 (1 Pt 1) 59–69 10.1111/j.1743‐6109.2009.01511.x [DOI] [PubMed] [Google Scholar]
  • 71. Pagnotta A, Tos P, Fornaro M, Gigante A, Geuna S, Battiston B. Neurotrophins and their receptors in early axonal regeneration along muscle‐vein‐combined grafts. Microsurgery, 2002, 22 (7) 300–303 10.1002/micr.10053 [DOI] [PubMed] [Google Scholar]
  • 72. Ganzer R, Blana A, Stolzenburg JU, Rabenalt R, Fritsche HM, Wieland WF et al. Nerve quantification and computerized planimetry to evaluate periprostatic nerve distribution‐does size matter?. Urology, 2009, 74 (2) 398–403 10.1016/j.urology.2008.12.076 [DOI] [PubMed] [Google Scholar]
  • 73. Abdel‐Gawad M, Huynh H, Brock GB. The impact of chronic renal failure on nitric oxide synthase isoforms gene expression in the penis and pelvic ganglia of rats. J Urol, 1999, 162 (4) 1473–1479 10.1016/S0022‐5347(05)68343‐7 [PubMed] [Google Scholar]
  • 74. Crutcher KA. The role of growth factors in neuronal development and plasticity. CRC Crit Rev Clin Neurobiol, 1986, 2 (3) 297–333 [PubMed] [Google Scholar]
  • 75. Hisasue S, Hashimoto K, Kobayashi K, Takeuchi M, Kyoda Y, Sato S et al. Baseline erectile function alters the cavernous nerve quantity and distribution around the prostate. J Urol, 2010, 184 (5) 2062–2067 10.1016/j.juro.2010.06.108 [DOI] [PubMed] [Google Scholar]
  • 76. Chuang MS, O'Connor RC, Laven BA, Orvieto MA, Brendler CB. Early release of the neurovascular bundles and optical loupe magnification lead to improved and earlier return of potency following radical retropubic prostatectomy. J Urol, 2005, 173 (2) 537–539 10.1097/01.ju.0000148941.57203.ec [DOI] [PubMed] [Google Scholar]
  • 77. Budaus L, Isbarn H, Schlomm T, Heinzer H, Haese A, Steuber T et al. Current technique of open intrafascial nerve‐sparing retropubic prostatectomy. Eur Urol, 2009, 56 (2) 317–324 10.1016/j.eururo.2009.05.044 [DOI] [PubMed] [Google Scholar]
  • 78. Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med, 2001, 7 (10) 1073–1074 10.1038/nm1001‐1073 [DOI] [PubMed] [Google Scholar]
  • 79. Lagoda G, Jin L, Lehrfeld TJ, Liu T, Burnett AL. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. J Sex Med., 2007, 4 (4 Pt 1) 908–916 10.1111/j.1743‐6109.2007.00519.x [DOI] [PubMed] [Google Scholar]
  • 80. Mulhall JP, Muller A, Donohue JF, Golijanin D, Tal R, Akin‐Olugbade Y et al. FK506 and erectile function preservation in the cavernous nerve injury model: optimal dosing and timing. J Sex Med, 2008, 5 (6) 1334–1344 10.1111/j.1743‐6109.2008.00776.x [DOI] [PubMed] [Google Scholar]
  • 81. Muller A, Tal R, Donohue JF, Akin‐Olugbade Y, Kobylarz K, Paduch D et al. The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. J Sex Med, 2008, 5 (3) 562–570 10.1111/j.1743‐6109.2007.00727.x [DOI] [PubMed] [Google Scholar]
  • 82. Canguven O, Lagoda G, Sezen SF, Burnett AL. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats. J Urol, 2009, 181 (6) 2816–2822 10.1016/j.juro.2009.01.097 [DOI] [PubMed] [Google Scholar]
  • 83. Paick JS, Lee SW. The neural mechanism of apomorphine‐induced erection: an experimental study by comparison with electrostimulation‐induced erection in the rat model. J Urol, 1994, 152 (6 Pt 1) 2125–2128 [DOI] [PubMed] [Google Scholar]
  • 84. Ball RA, Lipton SA, Dreyer EB, Richie JP, Vickers MA. Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function. J Urol, 1992, 148 (1) 211–215 [DOI] [PubMed] [Google Scholar]
  • 85. Jung GW, Spencer EM, Lue TF. Growth hormone enhances regeneration of nitric oxide synthase‐containing penile nerves after cavernous nerve neurotomy in rats. J Urol, 1998, 160 (5) 1899–1904 10.1016/S0022‐5347(01)62440‐6 [PubMed] [Google Scholar]
  • 86. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol, 2004, 171 (1) 495–500 10.1097/01.ju.0000089775.88825.ec [DOI] [PubMed] [Google Scholar]
  • 87. Allaf ME, Hoke A, Burnett AL. Erythropoietin promotes the recovery of erectile function following cavernous nerve injury. J Urol, 2005, 174 (5) 2060–2064 10.1097/01.ju.0000176808.94610.dd [DOI] [PubMed] [Google Scholar]
  • 88. Syme DB, Corcoran NM, Bouchier‐Hayes DM, Morrison WA, Costello AJ. The effect of androgen status on the structural and functional success of cavernous nerve grafting in an experimental rat model. J Urol, 2007, 177 (1) 390–394 10.1016/j.juro.2006.08.077 [DOI] [PubMed] [Google Scholar]
  • 89. Connolly SS, Yoo JJ, Abouheba M, Soker S, McDougal WS, Atala A. Cavernous nerve regeneration using acellular nerve grafts. World J Urol, 2008, 26 (4) 333–339 10.1007/s00345‐008‐0283‐y [DOI] [PubMed] [Google Scholar]

Articles from Reproductive Medicine and Biology are provided here courtesy of John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine.

RESOURCES